Exact Sciences and Flatiron Health, a healthtech company dedicated to improving cancer care and advancing research, are partnering to accelerate clinical evidence generation for Exact Sciences’ molecular residual disease test…
Invenra and Orion Corporation, a globally operating pharmaceutical company, announced recently that they have entered into a research collaboration to discover bispecific antibodies using Invenra’s B-Body platform. “This collaboration highlights…
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE Technologies has partnered with Antelope Surgical Solutions, a biotech company pioneering next-generation multimodal radiopharmaceuticals, the company announced recently. According to a release, the supply agreement will accelerate Antelope’s clinical…
SHINE Technologies is partnering with Primo Biotechnology, a developer of high-precision radiopharmaceuticals, the company announced today. According to a release, the agreement grants Primo exclusive distribution rights for SHINE’s Ilumira…
NorthStar Medical Radioisotopes and YAP Therapeutics are entering a collaboration agreement to develop and produce radiopharmaceuticals aimed at treating cancer and other chronic diseases, NorthStar announced today. According to a…
Axio BioPharma, an antibody manufacturing and process development company, announced recently that it is partnering with eMBR Genomics, a biotech company focused on early multi-cancer detection, to manufacture and distribute…
Imbed Biosciences named Terry Bromley its new Chief Executive Officer, the company announced recently. According to a release, Bromley has more than 30 years of experience in the medical device,…
NorthStar Medical Radioisotopes and Ariceum Therapeutics have signed a supply agreement for therapeutic medical radioisotope actinium-225 (Ac-225), the company announced recently. According to a release, NorthStar will supply non-carrier added…
AbbVie, a biotech company that develops and commercializes medicines, announced today that it will acquire Nimble Therapeutics. According to a release, the proposed acquisition adds Nimble’s lead asset, which is…
